INS and type 1 diabetes mellitus: These results suggest that Cap treatment can stimulate and assist in the functioning of the insulin signaling pathway, in the same way that was observed with muscle samples, in mice with T1D, and the absence of LTs may be related to the functioning of this pathway on liver.